140 related articles for article (PubMed ID: 16704435)
1. Transformed diffuse large B-cell lymphomas with gains of the discontinuous 12q12-14 amplicon display concurrent deregulation of CDK2, CDK4 and GADD153 genes.
Al-Assar O; Rees-Unwin KS; Menasce LP; Hough RE; Goepel JR; Hammond DW; Hancock BW
Br J Haematol; 2006 Jun; 133(6):612-21. PubMed ID: 16704435
[TBL] [Abstract][Full Text] [Related]
2. Copy number gain at 12q12-14 may be important in the transformation from follicular lymphoma to diffuse large B cell lymphoma.
Hough RE; Goepel JR; Alcock HE; Hancock BW; Lorigan PC; Hammond DW
Br J Cancer; 2001 Feb; 84(4):499-503. PubMed ID: 11207045
[TBL] [Abstract][Full Text] [Related]
3. Centroblastic and centroblastic/centrocytic lymphoma associated with a prominent epithelioid granulomatous response: a clinicopathologic study of 50 cases.
Kojima M; Nakamura S; Ichimura K; Suzuki R; Kagami Y; Kondo E; Motoori T; Hosomura Y; Oyama T; Itoh H; Ban S; Yoshida K; Ohno Y; Shimizu K; Masawa N; Sugihara S
Mod Pathol; 2002 Jul; 15(7):750-8. PubMed ID: 12118113
[TBL] [Abstract][Full Text] [Related]
4. The feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphoma.
Goy A; Stewart J; Barkoh BA; Remache YK; Katz R; Sneige N; Gilles F
Cancer; 2006 Feb; 108(1):10-20. PubMed ID: 16329118
[TBL] [Abstract][Full Text] [Related]
5. Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma.
Ree HJ; Yang WI; Kim CW; Huh J; Lee SS; Cho EY; Ko YH; Charney D
Hum Pathol; 2001 Sep; 32(9):954-62. PubMed ID: 11567225
[TBL] [Abstract][Full Text] [Related]
6. Bcl-2 gene rearrangement in Jordanian follicular and diffuse large B-cell lymphomas.
Almasri NM; Al-Alami J; Faza M
Saudi Med J; 2005 Feb; 26(2):251-5. PubMed ID: 15770300
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
Tagawa H
Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotypic and genotypic markers of follicular center cell neoplasia in diffuse large B-cell lymphomas.
King BE; Chen C; Locker J; Kant J; Okuyama K; Falini B; Swerdlow SH
Mod Pathol; 2000 Nov; 13(11):1219-31. PubMed ID: 11106080
[TBL] [Abstract][Full Text] [Related]
9. CD10 antigen expression correlates with the t(14;18)(q32;q21) major breakpoint region in diffuse large B-cell lymphoma.
Fang JM; Finn WG; Hussong JW; Goolsby CL; Cubbon AR; Variakojis D
Mod Pathol; 1999 Mar; 12(3):295-300. PubMed ID: 10102615
[TBL] [Abstract][Full Text] [Related]
10. Mutations of the 5' noncoding region of the BCL-6 gene in primary bone lymphomas.
Gianelli U; Ponzoni M; Moro A; Alfano RM; Pellegrini C; Giardini R; Patriarca C; Armiraglio E; Bosari S; Parafioriti A; Coggi G
Ann Hematol; 2003 Nov; 82(11):691-5. PubMed ID: 14513282
[TBL] [Abstract][Full Text] [Related]
11. MGMT methylation in diffuse large B-cell lymphoma: validation of quantitative methylation-specific PCR and comparison with MGMT protein expression.
Uccella S; Cerutti R; Placidi C; Marchet S; Carnevali I; Bernasconi B; Proserpio I; Pinotti G; Tibiletti MG; Furlan D; Capella C
J Clin Pathol; 2009 Aug; 62(8):715-23. PubMed ID: 19638543
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of chromosomal alteration of 3q27 on nodal B-cell lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 329 consecutive patients.
Niitsu N; Okamoto M; Nakamura N; Nakamine H; Aoki S; Hirano M; Miura I
Leuk Res; 2007 Sep; 31(9):1191-7. PubMed ID: 17197022
[TBL] [Abstract][Full Text] [Related]
13. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of interphase fluorescence in situ hybridization for the t(14;18)(q32;q21) translocation in the diagnosis of follicular lymphoma on fine-needle aspirates: a comparison with flow cytometry immunophenotyping.
Gong Y; Caraway N; Gu J; Zaidi T; Fernandez R; Sun X; Huh YO; Katz RL
Cancer; 2003 Dec; 99(6):385-93. PubMed ID: 14681948
[TBL] [Abstract][Full Text] [Related]
15. Clinical quantitation of diagnostic and predictive gene expression levels in follicular and diffuse large B-cell lymphoma by RT-PCR gene expression profiling.
Sakhinia E; Glennie C; Hoyland JA; Menasce LP; Brady G; Miller C; Radford JA; Byers RJ
Blood; 2007 May; 109(9):3922-8. PubMed ID: 17255358
[TBL] [Abstract][Full Text] [Related]
16. Sequential development of histiocytic sarcoma and diffuse large b-cell lymphoma in a patient with a remote history of follicular lymphoma with genotypic evidence of a clonal relationship: a divergent (bilineal) neoplastic transformation of an indolent B-cell lymphoma in a single individual.
Wang E; Papalas J; Hutchinson CB; Kulbacki E; Huang Q; Sebastian S; Rehder C; Silbermins D; Moore J; Datto M
Am J Surg Pathol; 2011 Mar; 35(3):457-63. PubMed ID: 21317718
[TBL] [Abstract][Full Text] [Related]
17. Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma.
Sagaert X; de Paepe P; Libbrecht L; Vanhentenrijk V; Verhoef G; Thomas J; Wlodarska I; De Wolf-Peeters C
J Clin Oncol; 2006 Jun; 24(16):2490-7. PubMed ID: 16636337
[TBL] [Abstract][Full Text] [Related]
18. MYD88 expression and L265P mutation in diffuse large B-cell lymphoma.
Choi JW; Kim Y; Lee JH; Kim YS
Hum Pathol; 2013 Jul; 44(7):1375-81. PubMed ID: 23380077
[TBL] [Abstract][Full Text] [Related]
19. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
[TBL] [Abstract][Full Text] [Related]
20. Identification of CCND3 and BYSL as candidate targets for the 6p21 amplification in diffuse large B-cell lymphoma.
Kasugai Y; Tagawa H; Kameoka Y; Morishima Y; Nakamura S; Seto M
Clin Cancer Res; 2005 Dec; 11(23):8265-72. PubMed ID: 16322284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]